Lonza’s 2nd Global Endotoxin Testing Summit

Published: 11-Mar-2016

23 - 25 May 2016

Conference

Annapolis, MD, and Pickering Beach, DE (USA)


The 2nd Global Endotoxin Testing Summit will address hot topics ranging from endotoxin testing basics to regulatory guidance updates and Low Endotoxin Recovery. The summit will also cover the use and relevance of naturally occurring endotoxin (NOE) in hold-time studies, explore new opportunities for process optimization and discuss ways to address variability associated with the kinetic chromogenic assay.

Visit www.lonza.com/endosummit

Trending Articles

  1. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  2. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  3. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  4. Chemspec Digital 19-20 June 2024 | Exhibition | Düsseldorf, Germany
  5. PHSS Annual Members Conference 2012 <b>11 October 2012</b><br> <i>Conference</i><br> Norton Park Hotel, Sutton Scotney, Hampshire

You may also like

Analysis

Lonza makes decision on new CEO

Wolfgang Wienand, currently CEO of Swiss CDMO Siegfried, will become Chief Executive Officer of Lonza in the summer of 2024
Cleaning

Lonza expands PyroCell pyrogen testing portfolio with two new rapid systems

Lonza has launched PyroCell MAT Rapid System and PyroCellMAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems containing the new PeliKine Human IL-6 Rapid ELISA Kit
Analysis

Lonza to phase out traditional endotoxin testing LAL and TAL assay reader for new tech

The company has launched the Nebula Absorbance Reader that is a technologically advanced, high-performance replacement reader, which delivers results comparable to those typically found with the traditional method and will facilitate the smooth continuation of current pyrogen and endotoxin testing programmes
Cleaning

Q&A on Lonza’s new PyroCell Monocyte Activation Test

Speaking to Katrin Pauls from Lonza about the launch of the company's PyroCell MAT, which uses human serum instead of foetal bovine serum for pharmaceutical testing, and how it changes the status quo
Cleaning

Lonza debuts first multimode reader to streamline quantitative endotoxin detection

The global science company has launched the Nebula Multimode Reader, the first multimode reader qualified for use with Lonza’s turbidimetric, chromogenic and recombinant endotoxin detection methods
Analysis

Lonza and Innosieve announce bioburden testing supply agreement

The Swiss contract manufacturer will sell and distribute a microbial diagnostic tool from the Dutch company
Manufacturing

Flexible and modular containment solutions for niche products

As pharmaceutical and biotech companies look to cater for more frequent product changes and smaller batches, the demand for flexibility, modularity and disposability have been the driver of innovation in containment equipment. Angharad Kolator Baldwin reviews developments in containment for 2017
Subscribe now